BRIDGEBIO PHARMA INC (BBIO) Institutional Shareholders
BRIDGEBIO PHARMA INC (BBIO) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $13.54B in BBIO holdings during the latest filing period.
Kohlberg Kravis Roberts & Co. L.P. is currently the largest disclosed institutional shareholder of BBIO tracked by InsiderSet, reporting ownership valued at approximately $987.68M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $905.72M, representing an estimated loss of -8.30% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 45% of the total disclosed BBIO value among the investors covered in this analysis. Major shareholders include Kohlberg Kravis Roberts & Co. L.P., Janus Henderson Group Plc, Blackrock, Inc., and several other long-term asset managers with concentrated positions in BRIDGEBIO PHARMA INC (BBIO).
This page ranks the largest institutional BBIO shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
454
Total Reported Value
$13.54B
Largest Holder
Kohlberg Kravis Roberts & Co. L.P.
Largest Position
$987.68M
Insider Transactions (90d)
38
Latest Filing Quarter
Q2 2026
New Institutional Positions
51
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | 17.30% | 13,260,971 | $987,677,120 | $905,724,319 | -$81,952,801 | -8.30% | |
| Janus Henderson Group Plc | 0.49% | 13,179,013 | $978,607,712 | $900,126,588 | -$78,481,124 | -8.02% | |
| Blackrock, Inc. | 0.01% | 10,287,156 | $766,187,363 | $702,612,755 | -$63,574,608 | -8.30% | |
| Viking Global Investors | Ole Andreas Halvorsen | 2.11% | 9,949,219 | $741,017,831 | $679,531,658 | -$61,486,173 | -8.30% |
| Vanguard Capital Management Llc | 0.01% | 7,898,973 | $588,315,509 | $539,499,856 | -$48,815,653 | -8.30% | |
| Vanguard Portfolio Management Llc | 0.03% | 7,656,722 | $570,272,655 | $522,954,113 | -$47,318,542 | -8.30% | |
| Wellington Management Group Llp | 0.07% | 5,308,924 | $395,408,660 | $362,599,509 | -$32,809,151 | -8.30% | |
| Two Sigma Investments, Lp | 0.26% | 4,722,185 | $351,708,339 | $322,525,236 | -$29,183,104 | -8.30% | |
| Aisling Capital Management Lp | 72.48% | 4,589,611 | $341,834,227 | $313,470,431 | -$28,363,796 | -8.30% | |
| State Street Corp | 0.01% | 4,435,932 | $330,388,215 | $302,974,156 | -$27,414,059 | -8.30% | |
| Citadel Advisors Llc | 0.16% | 3,760,028 | $280,046,885 | $256,809,912 | -$23,236,973 | -8.30% | |
| Invesco Ltd. | 0.02% | 3,700,934 | $275,645,564 | $252,773,792 | -$22,871,772 | -8.30% | |
| D. E. Shaw & Co., Inc. | 0.17% | 3,633,007 | $270,586,362 | $248,134,378 | -$22,451,984 | -8.30% | |
| Geode Capital Management, Llc | 0.01% | 3,418,419 | $254,669,075 | $233,478,018 | -$21,191,057 | -8.32% | |
| Jane Street Group, Llc | 0.14% | 2,934,193 | $218,538,695 | $200,405,382 | -$18,133,313 | -8.30% | |
| Banque Cantonale Vaudoise | 0.03% | 2,500 | $186,000,000 | $170,750 | -$185,829,250 | -99.91% | |
| Jpmorgan Chase & Co | 0.01% | 2,397,995 | $173,229,954 | $163,783,059 | -$9,446,896 | -5.45% | |
| Adage Capital Partners Gp, L.L.C. | 0.24% | 2,252,000 | $167,728,960 | $153,811,600 | -$13,917,360 | -8.30% | |
| Polar Capital Holdings Plc | 0.44% | 2,063,609 | $153,697,598 | $140,944,495 | -$12,753,103 | -8.30% | |
| Fmr Llc | 0.01% | 2,061,307 | $153,526,176 | $140,787,268 | -$12,738,908 | -8.30% | |
| Manufacturers Life Insurance Company, The | 0.11% | 1,955,733 | $145,662,994 | $133,576,564 | -$12,086,430 | -8.30% | |
| Sc Us (Ttgp), Ltd. | 0.43% | 1,860,364 | $138,559,911 | $127,062,861 | -$11,497,050 | -8.30% | |
| Goldman Sachs Group Inc | 0.01% | 1,814,657 | $135,155,654 | $123,941,073 | -$11,214,581 | -8.30% | |
| Ubs Group Ag | 0.02% | 1,757,152 | $130,872,681 | $120,013,482 | -$10,859,199 | -8.30% | |
| Price T Rowe Associates Inc | 0.01% | 1,726,383 | $128,582,000 | $117,911,959 | -$10,670,041 | -8.30% | |
| Charles Schwab Investment Management Inc | 0.02% | 1,709,417 | $127,317,378 | $116,753,181 | -$10,564,197 | -8.30% | |
| Norges Bank | 0.01% | 1,693,773 | $126,152,213 | $115,684,696 | -$10,467,517 | -8.30% | |
| Morgan Stanley | 0.01% | 1,693,652 | $126,143,276 | $115,676,432 | -$10,466,844 | -8.30% | |
| Ameriprise Financial Inc | 0.02% | 1,551,663 | $115,568,042 | $105,978,583 | -$9,589,459 | -8.30% | |
| Frazier Life Sciences Management, L.P. | 2.51% | 1,548,139 | $115,305,393 | $105,737,894 | -$9,567,499 | -8.30% | |
| Point72 Asset Management, L.P. | 0.17% | 1,525,782 | $113,640,243 | $104,210,911 | -$9,429,332 | -8.30% | |
| Alliancebernstein L.P. | 0.04% | 1,453,504 | $107,937,207 | $99,274,323 | -$8,662,884 | -8.03% | |
| Pictet Asset Management Holding Sa | 0.10% | 1,448,126 | $107,362,071 | $98,907,006 | -$8,455,065 | -7.88% | |
| Frontier Capital Management Co Llc | 0.95% | 1,373,057 | $102,265,291 | $93,779,793 | -$8,485,498 | -8.30% | |
| Laurion Capital Management Lp | 7.30% | 1,352,234 | $100,714,388 | $92,357,582 | -$8,356,806 | -8.30% | |
| Hood River Capital Management Llc | 0.73% | 1,347,535 | $100,364,407 | $92,036,641 | -$8,327,767 | -8.30% | |
| Bank Of America Corp | 0.01% | 1,235,380 | $92,011,099 | $84,376,454 | -$7,634,645 | -8.30% | |
| Balyasny Asset Management L.P. | 0.17% | 1,230,052 | $91,614,273 | $84,012,552 | -$7,601,721 | -8.30% | |
| Squarepoint Ops Llc | 0.17% | 1,191,732 | $88,760,199 | $81,395,296 | -$7,364,903 | -8.30% | |
| Bellevue Group Ag | 1.86% | 1,189,506 | $88,594,406 | $81,243,260 | -$7,351,146 | -8.30% | |
| Bnp Paribas Financial Markets | 0.04% | 1,155,442 | $86,057,320 | $78,916,689 | -$7,140,631 | -8.30% | |
| Gw&K Investment Management, Llc | 0.65% | 1,125,131 | $83,800,000 | $76,846,447 | -$6,953,553 | -8.30% | |
| Vanguard Fiduciary Trust Co | 0.02% | 1,116,989 | $83,193,341 | $76,290,349 | -$6,902,992 | -8.30% | |
| Hrt Financial Lp | 0.15% | 1,089,376 | $81,136,000 | $74,404,381 | -$6,731,619 | -8.30% | |
| Principal Financial Group Inc | 0.04% | 1,024,423 | $76,299,025 | $69,968,091 | -$6,330,934 | -8.30% | |
| Primecap Management Co/Ca/ | 0.04% | 1,015,980 | $75,670,190 | $69,391,434 | -$6,278,756 | -8.30% | |
| Fil Ltd | 0.05% | 1,002,260 | $74,648,325 | $68,454,358 | -$6,193,967 | -8.30% | |
| Clearbridge Investments, Llc | 0.06% | 993,103 | $73,966,324 | $67,828,935 | -$6,137,389 | -8.30% | |
| Northern Trust Corp | 0.01% | 959,513 | $71,464,528 | $65,534,738 | -$5,929,790 | -8.30% | |
| Citigroup Inc | 0.03% | 864,101 | $64,358,242 | $59,018,098 | -$5,340,144 | -8.30% |
Frequently asked questions about BBIO
Who owns the most BBIO stock?
The largest holders of BBIO are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for BRIDGEBIO PHARMA INC (BBIO).
Is BBIO widely held by superinvestors?
Many widely followed stocks like BBIO appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly BBIO is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.